Market Place
Sourcing Support
QIAGEN Supports Bundibugyo Ebolavirus Disease Surveillance
28 May 2026 //
BUSINESSWIRE
QIAGEN And NVIDIA Partner On AI Drug Discovery
21 May 2026 //
INDPHARMAPOST
QIAGEN Launches QIA Agent AI Platform for Scientific Workflows
20 May 2026 //
BUSINESSWIRE
Qiagen, Nvidia Partner to Advance AI Drug Discovery
20 May 2026 //
FIERCE BIOTECH
QIAGEN Partners with NVIDIA to Advance AI-Driven Drug Discovery
19 May 2026 //
PHARMIWEB
QIAGEN to Name Dr. Metin Colpan Honorary Chairman at 2026 AGM
12 May 2026 //
BUSINESSWIRE
QIAGEN Plans AI-Enabled TB Testing Workflow Launch
07 May 2026 //
PHARMIWEB
QIAGEN Reports Full Results for Q1 2026
06 May 2026 //
PHARMIWEB
QIAGEN Achieves Q1 2026 EPS Outlook, Updates Full-Year Forecast
27 Apr 2026 //
PHARMIWEB
QIAGEN Unveils Advanced Oncology Solutions At AACR 2026
16 Apr 2026 //
PHARMIWEB
QIAGEN Expands Into Bloodstream Infection Syndromic Testing
14 Apr 2026 //
PHARMIWEB
Parse Biosciences Launches FFPE-Compatible Single Cell Barcoding
31 Mar 2026 //
BUSINESSWIRE
Qiagen Announces Form 20-F Annual Report Filing For 2025 Results
20 Mar 2026 //
PHARMIWEB
QIAGEN Showcases Data Backing Quantiferon`s TB Prevention
19 Mar 2026 //
PHARMIWEB
QIAGEN Receives U.S. Clearance For Gastrointestinal Panels
11 Mar 2026 //
BUSSINESSWIRE
QIAGEN Exceeds Q4 2025 Outlook Driven By Growth Pillars
04 Feb 2026 //
BUSINESSWIRE
QIAGEN Unveils Qiasprint Connect System At SLAS 2026
03 Feb 2026 //
BUSINESSWIRE
QIAGEN Appoints Mark Stevenson To Supervisory Board
26 Jan 2026 //
BUSINESSWIRE
QIAGEN N.V. To Release Results For Q4 2025 And Hold Webcast
19 Jan 2026 //
BUSINESSWIRE
QIAGEN Sets 2026 Priorities to Drive Growth Across Five Units
12 Jan 2026 //
PHARMIWEB
QIAGEN Completes $500M Synthetic Share Repurchase
18 Dec 2025 //
BUSINESSWIRE
QIAGEN Partners With Pharma For CTC Research Advancement
18 Nov 2025 //
PHARMIWEB
QIAGEN Unveils Precision QIAsymphony Connect at AMP 2025
10 Nov 2025 //
BUSINESS WIRE
QIAGEN Acquires Parse Biosciences, Expanding Single-Cell Solution
04 Nov 2025 //
BUSINESSWIRE
Qiagen Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target
04 Nov 2025 //
BUSINESSWIRE
QIAGEN Introduces Automated Sexual Assault Sample Kit At ISHI
30 Oct 2025 //
BUSINESSWIRE
QIAGEN Marks 4,000th QIAcube Connect Placement
28 Oct 2025 //
BUSINESSWIRE
QIAGEN N.V. To Release Results For Q3 2025 And Hold Webcast
13 Oct 2025 //
PHARMIWEB
QIAGEN Earns CE-IVDR Certification for QIAstat-Dx Portfolio in EU
10 Sep 2025 //
PHARMAWEB
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise
02 Sep 2025 //
BUSINESSWIRE
Qiagen Sets Conversion Price for New Net Share Convertible Bonds
29 Aug 2025 //
PHARMAWEB
QIAGEN Announces Successful Placement of New Bonds
28 Aug 2025 //
BUSINESSWIRE
QIAGEN Sets Conversion Price of New Convertible Bonds
28 Aug 2025 //
BUSINESSWIRE
QIAGEN Surpasses Q2 2025 Outlook with Robust Growth
05 Aug 2025 //
BUSINESSWIRE
QIAGEN Launches QIAseq xHYB Long Read Panels, Expands Portfolio
22 Jul 2025 //
BUSINESSWIRE
QIAGEN Elects Stephen Rusckowski as Chairman
26 Jun 2025 //
BUSINESSWIRE
QIAGEN, GENCURIX Partner on QIAcuity Digital PCR IVD Assay
18 Jun 2025 //
BUSINESSWIRE
Qiagen, Incyte Team Up on MPN Companion Diagnostics
15 Jun 2025 //
BUSINESSWIRE
Tracer Biotechnologies partners with QIAGEN for MRD Testing
05 Jun 2025 //
BUSINESSWIRE
QIAGEN expands oncology testing with new strategic partnerships
02 Jun 2025 //
BUSINESSWIRE
Qiagen expands digital PCR oncology research with ID Solutions
22 May 2025 //
BUSINESSWIRE
QIAGEN to Propose Annual Cash Dividend at Shareholder Meeting
07 May 2025 //
BUSINESSWIRE
Qiagen exceeds Q1 2025 outlook, plans dividend, $500 mn repurchas
07 May 2025 //
BUSINESSWIRE
QIAGEN plans leadership transition in Supervisory Board
07 May 2025 //
BUSINESSWIRE
Qiagen Expands Digital PCR Portfolio With New Lentivirus Solution
29 Apr 2025 //
BUSINESSWIRE
QIAGEN Enhances Cancer Genomic Profiling at AACR 2025
22 Apr 2025 //
BUSINESSWIRE
Qiagen to Launch Three New Sample Prep Instruments by 2026
15 Apr 2025 //
BUSINESSWIRE
Qiagen to Release Results for Q1 2025 and Hold Webcast
08 Apr 2025 //
BUSINESSWIRE
Qiagen Gets US Nod For Second QIAstat-Dx GI Panel
06 Mar 2025 //
BUSINESSWIRE
QIAGEN Defends QuantiFERON IP in Latent TB Testing
03 Mar 2025 //
BUSINESSWIRE
QIAGEN Strengthens Bioinformatics with New Data Center in Australia
13 Feb 2025 //
BUSINESSWIRE
QIAGEN Details $300M Synthetic Share Repurchase Completion Plan
16 Jan 2025 //
BUSINESSWIRE
Qiagen To Return $300M To Shareholders Via Share Repurchase
12 Jan 2025 //
BUSINESSWIRE
QIAGEN Secures Clearance For QIAstat-Dx Mini GI Care Panel
09 Jan 2025 //
BUSINESSWIRE
QIAGEN Enhances QIAcuity PCR For Advanced Biological Insights
09 Jan 2025 //
BUSINESSWIRE
Qiagen Introduce Tool For Customizing Digital PCR Assays, NGS Panels
30 Nov 2024 //
PHARMABIZ
Qiagen Launches Tools for Customizing PCR Assays & NGS Panels
27 Nov 2024 //
GLOBENEWSWIRE
QIAGEN Partners with McGill to Advance Microbiome Research
12 Nov 2024 //
GLOBENEWSWIRE
Diagnostics firm Qiagen reports rise in third-quarter revenue
07 Nov 2024 //
REUTERS
Qiagen Delivers Solid Q3 2024 Growth, Increases EPS Outlook
06 Nov 2024 //
GLOBENEWSWIRE
